HIF1A and Hepatic fibrosis: Notably, the higher NIC dose further amplified the recovery, increasing the expression of these proteins by 3.52-, 3.85-, 4.48-, 2.47-, and 2.46-fold, while HIF-1α expression was reduced by 57.89% compared to the TAA-induced liver fibrosis group (Fig. 2A,G).